SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Nahid Shahabadi, Monireh Falsafi, Experimental and molecular docking studies on DNA binding interaction of adefovir dipivoxil: Advances toward treatment of hepatitis B virus infections, Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 2014, 125, 154

    CrossRef

  2. 2
    Yihu Zheng, Shengchu Zhang, Hooi Min Tan Grahn, Chao Ye, Zheng Gong, Qiyu Zhang, Prophylactic Lamivudine to Improve the Outcome of Breast Cancer Patients With HBsAg Positive During Chemotherapy: A Meta-Analysis, Hepatitis Monthly, 2013, 13, 4

    CrossRef

  3. 3
    Peter Karayiannis, Direct Acting Antivirals for the Treatment of Chronic Viral Hepatitis, Scientifica, 2012, 2012, 1

    CrossRef

  4. 4
    Dana Hocková, Antonín Holý, Graciela Andrei, Robert Snoeck, Jan Balzarini, Acyclic nucleoside phosphonates with a branched 2-(2-phosphonoethoxy)ethyl chain: Efficient synthesis and antiviral activity, Bioorganic & Medicinal Chemistry, 2011, 19, 15, 4445

    CrossRef

  5. 5
    Halis Simsek, Ali Shorbagi, Yasemin Balaban, Gonca Tatar, What is the optimum dose of adefovir in the treatment of chronic hepatitis B infection?, Journal of Hepatology, 2008, 49, 3, 464

    CrossRef

  6. 6
    S. G. LIM, P. MARCELLIN, N. TASSOPOULOS, S. HADZIYANNIS, T. T. CHANG, M. TONG, W. SIEVERT, P. HU, S. ARTERBURN, C. L. BROSGART, Clinical trial: effects of adefovir dipivoxil therapy in Asian and Caucasian patients with chronic hepatitis B, Alimentary Pharmacology & Therapeutics, 2007, 26, 10
  7. 7
    Do Young Kim, Hong Jeoung Kim, Chun Kyon Lee, Jeong Hun Suh, Dong Hwan Kim, Yong Suk Cho, Sun Young Won, Byung Kyu Park, In Suh Park, Efficacy of adefovir dipivoxil in the treatment of lamivudine-resistant hepatitis B virus genotype C infection, Liver International, 2007, 27, 1
  8. 8
    Tetsuya Hosaka, Fumitaka Suzuki, Yoshiyuki Suzuki, Satoshi Saitoh, Masahiro Kobayashi, Takashi Someya, Hitomi Sezaki, Norio Akuta, Yasuji Arase, Kenji Ikeda, Hiromitsu Kumada, Factors associated with the virological response of lamivudine-resistant hepatitis B virus during combination therapy with adefovir dipivoxil plus lamivudine, Journal of Gastroenterology, 2007, 42, 5, 368

    CrossRef

  9. 9
    Richard Harling, Deborah Turbitt, Michael Millar, Ines Ushiro-Lumb, Sandra Lacey, Gladys Xavier, Joanne Pope, Samreen Ijaz, Chong-Gee Teo, Passage from India: an outbreak of hepatitis B linked to a patient who acquired infection from health care overseas, Public Health, 2007, 121, 10, 734

    CrossRef

  10. 10
    Stephen Locarnini, William S. Mason, Cellular and virological mechanisms of HBV drug resistance, Journal of Hepatology, 2006, 44, 2, 422

    CrossRef

  11. 11
    MG Brook, R Gilson, E Wilkins, BHIVA guidelines on HIV and chronic hepatitis: coinfection with HIV and hepatitis B virus infection (2005), HIV Medicine, 2005, 6, S2
  12. 12
    Hari S. Conjeevaram, Disease status and therapeutic end points in hepatitis B, Current Hepatitis Reports, 2005, 4, 1, 5

    CrossRef

  13. 13
    Patrick Marcellin, Herve Mommeja-Marin, Stephen L. Sacks, George K. K. Lau, Daniel Sereni, Jean-Pierre Bronowicki, Brian Conway, Christian Trepo, M. Robert Blum, Byung Chul Yoo, Elsa Mondou, Jeff Sorbel, Andrea Snow, Franck Rousseau, Hyo-Suk Lee, A phase II dose-escalating trial of clevudine in patients with chronic hepatitis B, Hepatology, 2004, 40, 1
  14. 14
    Tetsuya Hosaka, Fumitaka Suzuki, Yoshiyuki Suzuki, Satoshi Saitoh, Masahiro Kobayashi, Takashi Someya, Hitomi Sezaki, Norio Akuta, Akihito Tsubota, Yasuji Arase, Kenji Ikeda, Hiromitsu Kumada, Adefovir Dipivoxil for Treatment of Breakthrough Hepatitis Caused by Lamivudine-Resistant Mutants of Hepatitis B Virus, Intervirology, 2004, 47, 6, 362

    CrossRef

  15. 15
    Man-Fung Yuen, Ching-Lung Lai, Adefovir dipivoxil in chronic hepatitis B infection, Expert Opinion on Pharmacotherapy, 2004, 5, 11, 2361

    CrossRef

  16. 16
    M. Danta, G. Dusheiko, Adefovir dipivoxil: review of a novel acyclic nucleoside analogue, International Journal of Clinical Practice, 2004, 58, 9
  17. 17
    Cindy J. Lai, Norah A. Terrault, Antiviral therapy in patients with chronic hepatitis B and cirrhosis, Gastroenterology Clinics of North America, 2004, 33, 3, 629

    CrossRef

  18. 18
    Chien-Hung Chen, Chuan-Mo Lee, Sheng-Nan Lu, Jing-Houng Wang, Hung-Da Tung, Chao-Hung Hung, Wei-Jen Chen, Chi-Sin Changchien, Comparison of clinical outcome between patients continuing and discontinuing lamivudine therapy after biochemical breakthrough of YMDD mutants, Journal of Hepatology, 2004, 41, 3, 454

    CrossRef

  19. 19
    B. Werle, K. Cinquin, P. Marcellin, S. Pol, M. Maynard, C. Trépo, F. Zoulim, Evolution of hepatitis B viral load and viral genome sequence during adefovir dipivoxil therapy, Journal of Viral Hepatitis, 2004, 11, 1
  20. 20
    D. Lavanchy, Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures, Journal of Viral Hepatitis, 2004, 11, 2
  21. 21
    M. S. Dai, P. F. Wu, R. Y. Shyu, J. J. Lu, T. Y. Chao, Hepatitis B virus reactivation in breast cancer patients undergoing cytotoxic chemotherapy and the role of preemptive lamivudine administration, Liver International, 2004, 24, 6
  22. 22
    Susanne Beckebaum, Vito R. Cicinnati, Guido Gerken, Christoph Erich Broelsch, Management of chronic hepatitis B in the liver transplant setting, Transplantation Reviews, 2004, 18, 4, 171

    CrossRef

  23. 23
    H. M. Younger, A. J. Bathgate, P. C. Hayes, Review article: nucleoside analogues for the treatment of chronic hepatitis B, Alimentary Pharmacology & Therapeutics, 2004, 20, 11-12
  24. 24
    Danny K.W. Soon, Stephen L. Lowe, Choo Hua Teng, Kwee Poo Yeo, James McGill, Stephen D. Wise, Safety and efficacy of alamifovir in patients with chronic hepatitis B virus infection, Journal of Hepatology, 2004, 41, 5, 852

    CrossRef

  25. 25
    Dana Hocková, Antonı́n Holý, Milena Masojı́dková, Graciela Andrei, Robert Snoeck, Erik De Clercq, Jan Balzarini, Synthesis and antiviral activity of 2,4-diamino-5-cyano-6-[2-(phosphonomethoxy)ethoxy]pyrimidine and related compounds, Bioorganic & Medicinal Chemistry, 2004, 12, 12, 3197

    CrossRef

  26. 26
    Roula B. Qaqish, Keri A. Mattes, David J. Ritchie, Adefovir dipivoxil: A new antiviral agent for the treatment of hepatitis B virus infection, Clinical Therapeutics, 2003, 25, 12, 3084

    CrossRef

  27. 27
    A.B Jain, J.J Fung, Advances in hepatitis B virus infection, Transplantation Proceedings, 2003, 35, 1, 342

    CrossRef

  28. 28
    MG Brook, R Gilson, EL Wilkins, BHIVA Guidelines: coinfection with HIV and Chronic hepatitis B virus, HIV Medicine, 2003, 4, S1
  29. 29
    Louise Cooley, Joseph Sasadeusz, Clinical and virological aspects of hepatitis B co-infection in individuals infected with human immunodeficiency virus type-1, Journal of Clinical Virology, 2003, 26, 2, 185

    CrossRef

  30. 30
    Hari S Conjeevaram, Anna Suk-Fong Lok, Management of chronic hepatitis B, Journal of Hepatology, 2003, 38, 90

    CrossRef

  31. 31
    Andy S Yu, Emmet B Keeffe, Nucleoside analogues and other antivirals for treatment of hepatitis B in the peritransplant period, Clinics in Liver Disease, 2003, 7, 3, 551

    CrossRef

  32. 32
    Erik De Clercq, Potential of acyclic nucleoside phosphonates in the treatment of DNA virus and retrovirus infections, Expert Review of Anti-infective Therapy, 2003, 1, 1, 21

    CrossRef

  33. 33
    Louise Cooley, Anna Ayres, Angeline Bartholomeusz, Sharon Lewin, Suzanne Crowe, Anne Mijch, Stephen Locarnini, Joseph Sasadeusz, Prevalence and characterization of lamivudine-resistant hepatitis B virus mutations in HIV–HBV co-infected individuals, AIDS, 2003, 17, 11, 1649

    CrossRef

  34. 34
    Russell H. Wiesner, Jorge Rakela, Michael B. Ishitani, David C. Mulligan, James R. Spivey, Jeffery L. Steers, Ruud A.F. Krom, Recent Advances in Liver Transplantation, Mayo Clinic Proceedings, 2003, 78, 2, 197

    CrossRef

  35. 35
    R Barcena Marugan, L Cid Gomez, P Lopez Serrano, Use of adefovir in the treatment of the chronic hepatitis B virus infection with resistance to lamivudine, Transplantation Proceedings, 2003, 35, 5, 1841

    CrossRef

  36. 36
    Milind Kamkolkar, Marcia M. Clayton, Shu Min Zhang, Paul Black, Raymond F. Schinazi, Mark A. Feitelson, Frontiers in Viral Hepatitis, 2003,

    CrossRef

  37. 37
    A randomized placebo-controlled trial of adefovir dipivoxil in advanced HIV infection: the ADHOC trial, HIV Medicine, 2002, 3, 4
  38. 38
    Justin G Julander, Robert W Sidwell, John D Morrey, Characterizing antiviral activity of adefovir dipivoxil in transgenic mice expressing hepatitis B virus, Antiviral Research, 2002, 55, 1, 27

    CrossRef

  39. 39
    Tim Shaw, Scott Bowden, Stephen Locarnini, Chemotherapy for hepatitis B: New treatment options necessitate reappraisal of traditional endpoints, Gastroenterology, 2002, 123, 6, 2135

    CrossRef

  40. 40
    Anastasia Rivkina, Sergey Rybalov, Chronic Hepatitis B: Current and Future Treatment Options, Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2002, 22, 6
  41. 41
    Sydney Tang, Stephen K. N. Ho, Kelly Moniri, Kar Neng Lai, Tak Mao Chan, EFFICACY OF FAMCICLOVIR IN THE TREATMENT OF LAMIVUDINE RESISTANCE RELATED TO AN ATYPICAL HEPATITIS B VIRUS MUTANT, Transplantation, 2002, 73, 1, 148

    CrossRef

  42. 42
    William E Delaney IV, Angeline Bartholomeusz, Stephen A Locarnini, Evolving therapies for the treatment of chronic hepatitis B virus infection, Expert Opinion on Investigational Drugs, 2002, 11, 2, 169

    CrossRef

  43. 43
    Nozomu Tanji, Kurenai Tanji, Neeraja Kambham, Glen S. Markowitz, Alvin Bell, Vivette D. D'Agati, Adefovir nephrotoxicity: Possible role of mitochondrial DNA depletion, Human Pathology, 2001, 32, 7, 734

    CrossRef

  44. 44
    Suzane Kioko Ono-Nita, Naoya Kato, Yasushi Shiratori, Masao Omata, Current options for the therapy of chronic hepatitis B infection, Current Infectious Disease Reports, 2001, 3, 2, 137

    CrossRef

  45. 45
    G. V. Papatheodoridis, S. J. Hadziyannis, Diagnosis and management of pre-core mutant chronic hepatitis B, Journal of Viral Hepatitis, 2001, 8, 5
  46. 46
    George K.K. Lau, HEPATITIS B INFECTION IN CHINA, Clinics in Liver Disease, 2001, 5, 2, 361

    CrossRef

  47. 47
    Anna S. Lok, E.Jenny Heathcote, Jay H. Hoofnagle, Management of hepatitis B: 2000—Summary of a workshop, Gastroenterology, 2001, 120, 7, 1828

    CrossRef

  48. 48
    B Werle, F Zoulim, Nouveaux traitements de l'hépatite B et techniques d'étude de la résistance virale, Immuno-analyse & Biologie Spécialisée, 2001, 16, 3, 158

    CrossRef

  49. 49
    Leonieke M. M. Wolters, Hubert G. M. Niesters, Robert A. de Man, Nucleoside analogues for chronic hepatitis B, European Journal of Gastroenterology & Hepatology, 2001, 13, 12, 1499

    CrossRef

  50. 50
    Y Benhamou, M Bochet, V Thibault, V Calvez, MH Fievet, P Vig, CS Gibbs, C Brosgart, J Fry, H Namini, C Katlama, T Poynard, Safety and efficacy of adefovir dipivoxil in patients co-infected with HIV-1 and lamivudine-resistant hepatitis B virus: an open-label pilot study, The Lancet, 2001, 358, 9283, 718

    CrossRef

  51. 51
    Antonín Holý, Ivan Votruba, Eva Tloušťová, Milena Masojídková, Synthesis and Cytostatic Activity of N-[2-(Phosphonomethoxy)alkyl] Derivatives of N6-Substituted Adenines, 2,6-Diaminopurines and Related Compounds, Collection of Czechoslovak Chemical Communications, 2001, 66, 10, 1545

    CrossRef

  52. 52
    Gregory J. Dore, David A. Cooper, The impact of HIV therapy on co-infection with hepatitis B and hepatitis C viruses, Current Opinion in Infectious Diseases, 2001, 14, 6, 749

    CrossRef

  53. 53
    Evelyn J. Fisher, Kathryn Chaloner, David L. Cohn, Lisa Bjorling Grant, Beverly Alston, Carol L. Brosgart, Barry Schmetter, Wafaa M. El-Sadr, James Sampson, The safety and efficacy of adefovir dipivoxil in patients with advanced HIV disease: a randomized, placebo-controlled trial, AIDS, 2001, 15, 13, 1695

    CrossRef

  54. 54
    Tim Shaw, Stephen Locarnini, Combination Chemotherapy for Hepatitis B Virus, Drugs, 2000, 60, 3, 517

    CrossRef

  55. 55
    Mark Wright, Janice Main, The prevention and management of viral hepatitis, Current Opinion in Infectious Diseases, 2000, 13, 5, 489

    CrossRef

  56. 56
    Basile Njei, Sushil Kumar, Eugene J Kongnyuy, Adefovir dipivoxil for chronic hepatitis B, The Cochrane Library,
  57. 57
    Basile Njei, Sushil Kumar, Eugene J Kongnyuy, Adefovir dipivoxil versus other antiviral drugs for chronic hepatitis B, The Cochrane Library,
  58. 58
    Ramachandra S. Hosmane, Antiviral Agents, Kirk-Othmer Encyclopedia of Chemical Technology,
  59. 59
    Veerendra Sandur, George Therapondos, Infections in the Liver,